SEARCH RESULT

Total Matching Records found : 3852

EU, Australia, Canada may follow India’s Patent Law -Divya Rajagopal

-The Economic Times MUMBAI: India's strong stance on minor drug innovations could reverberate in national parliaments and courthouses of the developed world as Australia, the EU and Canada get ready to discuss and ban patent protection for frivolous improvements. A top Australian government body on Wednesday asked for changes in its patent laws relating to drugs saying that the indiscriminate grant of patents to incremental innovations should be checked and that...

More »

Novartis patent ruling a victory in battle for affordable medicines-Sarah Boseley

-The Guardian Had Novartis won, it would have set a precedent for patenting of other medicines in India, delaying their reaching the poor   The battle for affordable, life-saving medicines for poor countries was once waged on first-world city streets with banners and placards. But for some years now it has been a long-hard legal slog in offices and courtrooms. A decade or so ago, it was mostly about access to Aids drugs. Firms...

More »

Novartis patent case: Glivec developer Brian Druker hails SC ruling- Chidanand Rajghatta

-The Economic Times WASHINGTON: Big Pharma found little support from the small guy on the street as the Indian Supreme Court's decision to reject patent claims of the drug maker Novartis for its celebrated cancer medicine Glivec reverberated across the world. The pharma lobby railed against the decision but the overwhelming sentiment, from physicians to politicians, from academia to media, particularly in a country groaning from the high cost of health care,...

More »

Domestic firms rejoicing on Glivec verdict-Sushmi Dey

-The Business Standard Now, local firms can sell their low-priced generic version of the drug in India and export it to developing markets, where it is not patented Domestic drug firms such as Cipla, Natco, Ranbaxy and Hetero are a happier lot following the Supreme Court verdict on Monday, dismissing Novartis AG's patent plea for anti-cancer drug imatinib mesylate or Glivec, as sold by the Swiss drug maker. This is because the judgement...

More »

Man-made drought

-The Business Standard Politics means sugarcane gets Maharashtra's scarce water The drought in a large part of Maharashtra, said to be the worst since 1972, may have been triggered by poor rainfall in the last monsoon season - but it has been compounded by mismanagement of the available water. Nearly one-third of the state's population living in the 15 drought-hit districts in and around the Marathwada region is facing a severe scarcity...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close